Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

Recruiting N/A Interventional Study
Inflammatory Bowel Disease (IBD) Medication Compliance Quality of Life Telehealth Monitoring
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
120 (estimated)
Sponsor
Istanbul University - Cerrahpasa · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Individuals aged 18 years or older * Individuals aged 18 years or older * Able to read and write in Turkish * Diagnosed with inflammatory bowel disease (IBD) for at least 6 months * In clinical remission (Harvey-Bradshaw Index score \< 5 or Simple Clinical Colitis Activity Ind…
Contacts

Kimya Kılıçaslan, PhD Candidate

+90 535 083 45 53

kimya.kilicaslan@iuc.edu.tr

CONTACT

Zeliha Tulek, PhD, Prof.

+90 532 776 29 93

ztulek@iuc.edu.tr

CONTACT